Elsevier, Maturitas, Volume 126, August 2019
This review discusses established transgender individuals on hormones who have reached their desired post-pubertal phenotype. Current guidelines have not clearly integrated specific considerations for the older population. This review focuses on changes in physiology with age, recommended maintenance therapy and safety evaluation to mitigate the risks of hormone therapy with a focus on the older population.
Category:
Keywords:
Androgen Antagonists; Androgen Therapy; Antiandrogen; Bicalutamide; Cochrane Library; Conjugated Estrogen; Drug Safety; Dutasteride; Estradiol; Estradiol Cipionate; Estradiol Valerate; Estrogen; Estrogens; Ethinylestradiol; Female To Male Transgender; Finasteride; Hormonal Therapy; Hormone; Hormone Regimen; Hormone Safety; Human; Humans; Male To Female Transgender; Medline; Patient Education; Review; Sex Reassignment; Sex Reassignment Procedures; Spironolactone; Systematic Review; Testosterone; Testosterone Blood Level; Testosterone Cipionate; Testosterone Enantate; Testosterone Undecanoate; Transgender; Transgender Persons; Global
